Characterization of the binding of endothelin ET(B) selective ligands in human and rat heart

British Journal of Pharmacology

Volumn 119, Issue 4, 1996, Pages 631-636

  Russell, Fraser D ^a   Davenport, Anthony P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

BQ788; Endothelin; ET(A) receptors; ET(B) receptors; ET 3; IRL2500; RES 701 1; Sarafotoxin S6c

Indexed keywords

ENDOTHELIN 3; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; IRL 2500; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N (HEXAHYDRO 1 AZEPINYLCARBONYL)LEUCYL(1 METHYL DEXTRO TRYPTOPHYL) DEXTRO TYROSINE; RADIOPHARMACEUTICAL AGENT; SARAFOTOXIN S6C; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; COMPETITIVE INHIBITION; DISSOCIATION CONSTANT; FEMALE; HEART LEFT VENTRICLE; HUMAN; HUMAN TISSUE; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

EID: 0029858496     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15720.x     Document Type: Article

References (34)

1. AKIYAMA, N., HIRAOKA, O., FUJII, Y., TERASHIMA, H., SATOH, M., WADA, K. & FURUICHI, Y. (1992). Biotin derivatives of endothelin: utilization for affinity purification of endothelin receptor. Protein Expression Purification, 3, 427-433.
2. BAX, W.A., BRUINVELS, A.T., VAN SUYLEN, R.-J., SAXENA, P.R. & HOYER, D. (1993), Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis. Naunyn-Schmiedeberg's Arch Pharmacol., 348, 403-410.
3. B. Identification of regions involved in the selectivity for endothelin 3 or cyclo-(D-Trp-D-Asp-Pro-D-Val-Leu). Eur. J. Biochem., 221, 951-958
4. B receptors. Br. J. Pharmacol., 112, 1251-1257.
5. COCKCROFT, J.R., CLARKE, J.G. & WEBB, D.J. (1991). The effect of intra-arterial endothelin on resting blood flow and sympathetically mediated vasoconstriction in the forearm of man. Br. J. Clin. Pharmacol., 31, 521-524.
6. A receptors. Br. J. Pharmacol., 111, 4-6.
7. A receptors in humans? Trends Pharmacol. Sci., 15, 9-11.
8. A sub-type. Br. J. Pharmacol., 114, 1110-1116.
9. HE, J.X., CODY, W.L., FLYNN, MA., WELCH, K.M., REYNOLDS, E.E. & DOHERTY, A.M. (1995). RES-701-1, synthesis and a reevaluation of its effects on the endothelin receptors. Bioorganic Med. Chem. Lett., 5, 621-626.
10. ISHIKAWA, K., IHARA, M., NOGUCHI, K., MASE, T., MINO, N., SAEKI, T., FUKURODA, T., FUKAMI, T., OZAKI, S., NAGASE, T., NISHIKIBE, M. & YANO, M. (1994). Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. U.S.A., 91, 4892-4896.
11. 125I]BQ3020. Brain Res., 665, 33-38.
12. KOBAYASHI, S., TANG, R., WANG, B., OPGENORTH, T., LANGENSTROER, P., SHAPIRO, E. & LEPOR, H. (1994). Binding and functional properties of endothelin receptor subtypes in the human prostate. Mol. Pharmacol., 45, 306-311.
13. MAGGI, M., VANNELLI, G.B., FANTONI, G., BALDI, E., MAGINI, A., PERI, A., GIANNINI, S., GLORIA, L., DEL CARLO, P., CASPARIS, D., TOMEI, T. & SERIO, M. (1994). Endothelin in the human uterus during pregnancy. J. Endocrinol., 142, 385-396.
14. A receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br. J. Pharmacol., 115, 191-197.
15. MAUZY, C., WU, L.-H., EGLOFF, A.M., MIRZADEGAN, T. & CHUNG, F.-Z. (1992). Substitution of lysine-181 to aspartic acid in the third transmembrane region of the endothelin (ET) type B receptor selectivity reduces its high-affinity binding with ET-3 peptide. J. Cardiovasc. Pharmacol., Supp. 12, S5-S7.
16. MCPHERSON, G.A. (1983). A practical computer-based approach to the analysis of radioligand binding experiments. Comput. Programs Biomed., 17, 107-113.
17. MILLER, V. & MICHENER, S.R. (1995). Modulation of contractions to and receptors for endothelins in canine veins. Am. J. Physiol., 268, H345-H350.
18. 1,3,11,15]ET-1 in human heart. Br. J. Pharmacol., 107, 637-639.
19. MOLENAAR, P., O'REILLY, G., SHARKEY, A., KUC, R.E., HARDING, D.P., PLUMPTON, C., GRESHAM, A. & DAVENPORT, A.P. (1993). Characterization and localization of endothlin receptor subtypes in the human atrioventricular conducting system and myocardium. Cir. Res., 72, 526-538.
20. MORISHITA, Y., CHIBA, S., TSUKUDA, E., TANAKA, T., OGAWA, T., YAMASAKI, M., YOSHIDA, M., KAWAMOTO, I. & MATSUDA, Y. (1994). RES-701-1, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. 1. Characterization of producing strain, fermentation isolation, physico-chemical and biological properties. J. Antibiotics, 47, 269-275.
21. MUNSON, P.J. & RODBARD, D (1980). LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220-239.
22. B-selective agonist, displays species differences in its binding characteristics. Neuropeptides, 28, 191-196.
23. 125I]IRL-1620, a potent agonist specific for endothelin-B receptors. J. Pharmacol. Exp. Ther., 268, 202-207.
24. B-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells. Biochem. Biophys. Res. Commun., 209, 483-489.
25. REYNOLDS, E.E., HWANG, O., FLYNN, M.A., WELCH, K.M., CODY, W.L., STEINBAUGH, B., HE, J.X., CHUNG, F.-Z. & DOHERTY, A.M. (1995). Pharmacological differences between rat and human endothelin B receptors. Biochem. Biophys. Res. Commun., 209, 506-512.
26. SAKAMOTO, A., YANAGISAWA, M., SAWAMURA, T., ENOKI, T., OHTANI, T., SAKURAI, T., NAKAO, K., TOYO-OKA, T. & MASKI, T. (1993). Distinct subdomains of human endothelin receptors determine their selectivity to endothelin A-selective antagonist and endothelin B-selective agonists. J. Biol. Chem., 268, 8547-8553.
27. SOGABE, K., NIREI, H., SHOUBO, M., HAMADA, K., NOMOTO, A., HENMI, K., NOTSU, Y. & ONO, T. (1992). A novel endothelial receptor antagonist: studies with FR139317. J. Vasc. Res., 29, 201-202.
28. SOKOLOVSKY, M. (1995). Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. Pharmacol. Ther., 68, 435-471.
29. B receptor-selective antagonist. Biochem. Biophys. Res. Commun., 209, 712-716.
30. TANAKA, T., TSUKUDA, E., NOZAWA, M., NONAKA, H., OHNO, T., KASE, H., YAMADA, K. & MATSUDA, Y. (1994). RES-701-1, a novel, potent, endothelin type B receptor selective antagonist of microbial origin. Mol. Pharmacol., 45, 724-730.
31. WILLIAMS, D.L. JR., JONES, K.L., COLTON, C.D. & NUTT, R.F. (1991). Identification of high affinity endothelin-1 receptor subtypes in human tissues. Biochem. Biophys. Res. Commun., 180, 475-480.
32. YAMAGA, S., TSUTSUMI, K., NIWA, M., KITAGAWA, N., ANDA, T., HIMENO, A., KHALID, H., TANIYAMA, K & SHIBATA, S. (1995). Endothelin receptor in microvessels isolated from human meningiomas: quantification with radioluminography. Cell. Mol. Neurobiol, 15, 327-340.
33. YANO, K., YAMASAKI, M., YOSHIDA, M., MATSUDA, Y. & YAMAGUCHI, K. (1995). RES-701-2, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. II. Determination of the primary structure. J. Antibiotics, 48, 1368-1370.
34. ZHU, G., WU, L.-H., MAUZY, C., EGLOFF, A.M., MIRZADEGAN, T. & CHUNG, F.-Z. (1992). Replacement of lysine-181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling. J. Cell Biochem., 50, 159-164.